Monthly News Roundup - April 2023

Qulipta Use Expanded to Include Chronic Migraine Prevention in Adults
People living with chronic migraine have headaches for at least 15 days per month, with at least 8 of those 15 days associated with migraine. Qulipta (atogepant), an oral,...